Objective To evaluate transitional changes in 
Introduction

To date, although there have been a few reports on the performance of individual interferon-γ release assays (IGRAs; QFT-2G test or T-SPOT.TB test) on serial testing (1, 2) for latent TB infection (LTBI) or active TB, there are no published data on the performance of IGRAs in serial tests in the same patient with active TB over a three-year period. It is necessary to generate evidence regarding the variability of IFN-γ responses during serial testing over long-term follow-up, frequency of conversions and reversions, and thresholds to distinguish cure or relapse of active TB. Therefore, we prospectively evaluated transitional changes in QFT-2G test results in serial testing for three years after the initiation of antituberculosis treatment for patients with active TB and reevaluated the optimal threshold of positive response as a cure of TB infection.
Methods
Twenty-two patients were confirmed to be positive for
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the influence of active TB or LTBI treatment on the Tcell response to MTB-specific antigens, two reports using the ELISPOT method showed declines in T-cell response to ESAT-6 with treatment of active TB in small numbers of patients. Nicol et al reported an early increase in ELISPOT responses to ESAT-6 and CFP-10 followed by a decline after three and six months of active TB treatment in ten children (4). Aiken et al showed declines in ESAT-6 and CFP-10 ELISPOT counts after successful TB treatment 12 months after diagnosis in 89 patients with TB in Gambia (5). In our previous study (6), IGRAs using QFT-2G tests showed a significant transitional decrease between the initiation of antituberculosis treatment and the finish of treatment. Concerning the reason that the IFN-γ response was maintained without a decrease after the completion of antituberculosis treatment, we cannot clarify whether the persistence of IFN-γ response is dependent upon the T-cell immunity of the individual patient, on the bacterial virulence, or on the cut-off level of QFT-2G test.
In order to resolve the second problem, we challenged the change in conversion criteria from a positive response to a 
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QFT-2G test result
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